86.34
BATS BZX Real-Time Price
As of 10:47am ET
 +0.83 / +0.97%
Today’s Change
80.85
Today|||52-Week Range
153.15
-8.84%
Year-to-Date
Zacks.com featured highlights include: Incyte, Altice USA, Archrock, Live Nation and...
9:07am / Zacks.com - Paid Partner Content
Why Incyte (INCY) Might Surprise This Earnings Season
Feb 14 / Zacks.com - Paid Partner Content
Get Rid of 5 Toxic Stocks or Sell Short for Profit
Feb 19 / Zacks.com - Paid Partner Content
Can Jakafi Performance Drive Incyte's (INCY) Q4 Earnings?
Feb 12 / Zacks.com - Paid Partner Content
Incyte (INCY) Beats on Q4 Revenues on Strong Jakafi Sales
Feb 15 / Zacks.com - Paid Partner Content
Will Prothena (PRTA) Disappoint Investors in Q4 Earnings?
Feb 09 / Zacks.com - Paid Partner Content
Incyte (INCY) Beats on Sales in Q4
Feb 15 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close85.51
Today’s open85.66
Day’s range85.06 - 86.91
Volume26,390
Average volume (3 months)1,722,437
Market cap$18.1B
Data as of 10:47am ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)-383.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+57.90%
Revenue growth (last year)+38.93%
P/E ratioNM
Price/Sales12.61
Price/Book11.08

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.25+1.56%
ALXNAlexion Pharmaceutic...-0.91-0.77%
BAXBaxter International...+0.56+0.84%
MYLMylan NV+0.47+1.14%
Data as of 10:47am ET, 02/21/2018

Financials

Last reporting dateFebruary 15, 2018
EPS forecast (this quarter)-$0.48
Annual revenue (last year)$1.5B
Annual profit (last year)-$313.1M
Net profit margin-20.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts